Our data demonstrate that CLL cells express CD69 and CD80 at levels that approximate the levels observed in activated B cells and that CLL cells express CD86 at levels intermediate between naïve and stimulated B cells. The gene discussed is CD86; the disease is B-cell chronic lymphocytic leukemia.